Appili Therapeutics Inc Class A Financial Overview
Appili Therapeutics Inc Class A's market cap is currently $2.22M. The company's EPS TTM is $-0.005847736; its P/E ratio is -1.19; Appili Therapeutics Inc Class A is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
